协同共刺激分子B7-H4与肿瘤关系的研究进展
被引量:1
摘要
肿瘤是威胁人类健康的恶性疾病,在其发生发展过程中,T细胞活化和耐受的免疫调节起着至关重要的作用,其中B7-CD28家族成员介导的T细胞共刺激信号转导,不仅在启动、增强和维持T细胞应答中提供了关键的正性信号,而且还可提供重要的负性信号来限制、终止或削弱T细胞的免疫应答。
出处
《河北医科大学学报》
CAS
2010年第1期116-118,共3页
Journal of Hebei Medical University
参考文献18
-
1CARRENO BM, COLINS M. B7 family of ligands and its receptors:new pathways for costimulation and inhibition of immune response [J]. Annu Rev Immunol, 2002,20 (1) : 29- 53.
-
2SICA GL,CHOI IH,ZHU G,et aL B7-H4,a molecule of the B7 family, negatively regulates T cell immunity [J]. Immunity,2003,18(6) :849-861.
-
3ZANG X,LOKE P,KIM J, et al. B7x: a widely expressed B7 family member that inhibits T cell activation[J]. Proc Natl Acad Sci, 2003,100(18) : 10388-10392.
-
4PRASAD DV,RICHARDS S, MAI XM, et al. B7S1, a novel B7 family member that negatively regulates T cell activation [J]. Immunity, 2003,18 (6) : 863-873.
-
5魏双燕,姜洁,南芳芳,成磊.卵巢浆液性癌B7-H4的表达及临床病理意义[J].现代妇产科进展,2008,17(7):493-496. 被引量:8
-
6SIMON I, KATSAROS D, RIGAULT DL, et al. B7-H4 is over expressed in early-stage ovarian cancer and is independent of CA125 expression [ J]. Gynecol Oncol, 2007, 106(2) :334-341.
-
7SINOM I,LIU Y,KRALL KL, et al. Evaluation of the novel serum markers B7-H4, Spondin2,and DcR3 for diagnosis and early detection Of ovarian cancer[J]. Gynecol Oncol, 2007,106 (1):112-118.
-
8OIKONOMOPOULOU K, LI L, ZHENG Y, et al. Prediction of ovarian cancer prognosis and response to ehemotherapy by a serum-based multiparametrie biomarker panel [J]. Br J Cancer,2008,99(7) :1103- 1113.
-
9刘杰,孙玉萍,汪运山,刘惠萍,张秀兰.B7-H4在乳腺癌中表达的临床意义[J].临床肿瘤学杂志,2007,12(11):830-832. 被引量:5
-
10MUGLER KC, SINGH M, TRINGLER B, et al. B7-H4 expression in a range of breast pathology: correlation with tumor T-cell infiltration [J]. Appl Immunohistochem Mol Mor Phol, 2007,15(4) : 363-370.
二级参考文献27
-
1Aunoble B,Sanches R,Didier E,et al.Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review)[J].Int J Oncol,2000,16(3):567-576.
-
2Nicosia SV,Bai J,Cheng Q,et al.Oncogenic pathways implicated in ovarian epithelial cancer[J].Hematol Oncol Clin North Am,2003,17(4):927-943.
-
3Salceda S,Tang T,Kmet M,et al.The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation[J].Exp Cell Res,2005,306(1):128-141.
-
4Konishi J,Yamazaki K,Azuma M,et al.B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression[J].Clin Cancer Res,2004,10(15):5094-5 100.
-
5Schirmmcher V,Feuerer M,Beckhove P,et al.T cell memory,anergy and immunotherapy in breast cancer[J].J Mammary Gland Biol Neoplasia,2002,7(2):201-208.
-
6Hadden JW.The immunology and immunotherapy of breast cancer:an update[J].Int J Immunopathol Pharmacol,1999,21(2):79-101.
-
7Prasad DV,Richards S,Mai XM,et al.B7S1,a nnovel B7 family member that negatively regulates T cell activation[J].Immunity,2003,18(6):863-873.
-
8Sica GL,Choi IH,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell[J].Immunity,2003,18(6):849-861.
-
9Strome SE,Dong H,Tamurra H,et al.B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma[J].Cancer Res,2003,63(19):6 501-6 505.
-
10Sica GI, Choi Ih, Zhu Gm, et al. B7-H4, a molecule of the B7 family, negatively regulates T cells immunity [ J ]. Immunity, 2003, 18(6) : 849 -861.
共引文献20
-
1华建江,姜健,胡国艳,郑淑华,刘伟,吕晶,徐军发.胃癌患者血清可溶性B7-H4的检测及其临床意义[J].山东大学学报(医学版),2009,47(8):100-102. 被引量:1
-
2廖林虹,于晓红.B7-H4在卵巢浆液性癌组织中的表达及其临床意义[J].实用癌症杂志,2010,25(5):473-475. 被引量:2
-
3傅振坤,章婕,李殿俊.B7-H4与肿瘤关系的研究进展[J].国际免疫学杂志,2008,31(1):32-34. 被引量:2
-
4陶岚,张立煌(审校).新型共刺激分子B7-H4在肿瘤免疫中的研究进展[J].国际免疫学杂志,2009,32(1):20-24.
-
5郭莉婷(综述),姜藻(审校).肿瘤组织中B7-H4的表达及意义[J].国际肿瘤学杂志,2009,36(7):497-499.
-
6何素丽,杜丹丽.B7-H4、hK6用于卵巢癌早期诊断的研究进展[J].蚌埠医学院学报,2009,34(11):1051-1052. 被引量:3
-
7胡文蔚,蒋敬庭,吴昌平.协同刺激分子B7-H4在恶性肿瘤中的表达意义[J].医学综述,2010,16(1):52-54. 被引量:3
-
8张彩娣,史建平,王凤鸣,徐秋岚,陈宝华.负性协同刺激分子B7-H4在非小细胞肺癌组织中的表达及其临床意义[J].中国肿瘤生物治疗杂志,2009,16(6):633-636. 被引量:3
-
9郭莉婷,陈颖,程月新,邵伟伟,顾晓怡,姜藻.胃癌组织中B7-H4的表达及其临床意义[J].东南大学学报(医学版),2010,29(3):306-311. 被引量:2
-
10何素丽,杜丹丽.B7-H4蛋白及CA125在卵巢上皮性癌患者血清中的表达及其临床意义[J].中华妇产科杂志,2010,45(6):455-457. 被引量:8
同被引文献22
-
1廖林虹,于晓红.B7-H4在卵巢浆液性癌组织中的表达及其临床意义[J].实用癌症杂志,2010,25(5):473-475. 被引量:2
-
2Ratto C,Costa R,Vassallo C,et al.Twelve-year experience with left atrial resection in the treatment of non--small cell lung cancer [J].Ann Thorac Surg,2004,78(1 ):234-237.
-
3Boyle P,Levin B.Wodd cancer report 2008 [M].Lyon Cedex : IARC Press, 2008:422-423.
-
4Fields M,Chevlen E.Ovarian cancer screening:a look at the evidenee[J].Clin J Oneol Nurs,2006,10( 1 ):77-81.
-
5Tringler B,Liu W,Corral L,et al.B7-H4 overexpression in ovarian tumors[J].Gynecol Oncol, 2006,100( 1 ):44-52.
-
6Sica G L,Choi I H,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity [J]. Immunity, 2003,18 (6) :849-861.
-
7Prasad D V,Rieards S,Mal X M,et al.B7S1 ,a novel B7 family member that negatively regulates T cell activation [ J ] .Immunity, 2003,18 (6) :863-873.
-
8Zang X ,Loke P, Kim J ,et al.B7x:a widely expressed B7 family member that inhibits T cell activation [J].Proc Natl Acad Sci USA,2003,100(18):10388-10392.
-
9Zang X,Thompson R H,A1 Ahmadie H A,et al.B7-H3and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome[J]. Proc Natl Acad Sci USA,2007,104(49):19458-19463.
-
10TringIer B,Zhuo S,Pilkington G,et al.B7-H4 is highly expressed in ductal and lobular breast cancer [J].Clin Cancer Res, 2005,11 (5): 1842-1848.
-
1黄元华,徐雯.人类胚胎干细胞的建系与维持[J].海南医学院学报,2006,12(1):77-81.
-
2杨琳,柯杨.非编码RNA——功能基因组研究的新热点[J].北京大学学报(医学版),2006,38(4):444-446. 被引量:4
-
3银桂彬,梁杰,罗少军.腺病毒载体的研究进展[J].广东医学院学报,2007,25(5):581-583. 被引量:4
-
4李进,高箬远,陈俊羽,李天明.单核苷酸多态性与肺癌关系的研究进展[J].云南师范大学学报(自然科学版),2013,33(4):71-74. 被引量:2
-
5杨建营,徐翔峰,向珍蛹.NF-κB的研究进展[J].淮海医药,2011,29(1):93-94. 被引量:11
-
6曾今诚,林观平,周克元.PTEN信号途径与肿瘤相关研究进展[J].广东医学院学报,2010,28(2):193-196. 被引量:15
-
7庞玲品,黄石安.血管平滑肌细胞表型转化相关因素及机制的研究进展[J].广东医学院学报,2010,28(3):312-314. 被引量:4
-
8王保琳.基因治疗载体的研究进展[J].淮海医药,2011,29(2):187-188. 被引量:3
-
9裴永彬,贺新奇,赵增仁.石蜡包埋组织中DNA提取技术研究进展[J].河北医科大学学报,2010,31(11):1396-1399. 被引量:2
-
10郭仕华,娄红祥,贺艳丽.基因药物在肿瘤治疗中的应用与发展[J].食品与药品,2005,7(12A):9-10.